-
Product Insights
Likelihood of Approval Analysis for Nociceptive Pain
Overview How likely is it that the drugs in Nociceptive Pain will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Nociceptive Pain Overview Nociceptive pain is a type of pain caused by...
-
Product Insights
Likelihood of Approval Analysis for Venous Thromboembolism
Overview How likely is it that the drugs in Venous Thromboembolism will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Venous Thromboembolism Overview Venous thromboembolism (VTE) is a condition that occurs when...
-
Product Insights
Likelihood of Approval Analysis for Acute Heart Failure
Overview How likely is it that the drugs in Acute Heart Failure will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Acute Heart Failure Overview Acute heart failure (AHF) is a critical...
-
Product Insights
Likelihood of Approval Analysis for Epilepsy
Overview How likely is it that the drugs in Epilepsy will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Epilepsy Overview Epilepsy is a group of non-communicable neurological disorders characterized by recurrent...
-
Product Insights
Likelihood of Approval Analysis for Respiratory Distress Syndrome
Overview How likely is it that the drugs in Respiratory Distress Syndrome will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Respiratory Distress Syndrome Overview Respiratory distress syndrome (RDS) occurs in babies...
-
Sector Analysis
NewMexico Upstream (Oil and Gas) Fiscal and Regulatory Guide, 2024
Mexico Upstream Fiscal and Regulatory Report Overview The upstream fiscal and regulatory outlook of Mexico has undergone many changes. Mexico has implemented different regimes for oil exploration and production, including Production Sharing Agreements (PSAs), Concession Agreements, Service Contracts, and PEMEX's Entitlement Regime. Private development of fields has been halted since 2018, when President Lopez Obrador put a stop to Licensing Rounds in a bid to position PEMEX as the sole player in upstream development, with the company already securing a...
-
Product Insights
Likelihood of Approval Analysis for Idiopathic Pulmonary Fibrosis
Overview How likely is it that the drugs in Idiopathic Pulmonary Fibrosis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Idiopathic Pulmonary Fibrosis Overview Idiopathic pulmonary fibrosis (IPF), or (formerly) fibrosing...
-
Product Insights
Clot Management Devices Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Clot Management Devices Pipeline Market Report Overview Clot Management Devices are used for the removal or dissolution of a clot from a blood vessel to restore proper blood circulation. This device is used as a routine procedure while performing percutaneous coronary intervention and for treating potentially life-threatening complications. The clot management devices pipeline market research report provides comprehensive information on the products with their comparative segment-wise analysis in various stages of development. The report also covers the regional and country-wise...
-
Product Insights
Likelihood of Approval Analysis for Neutropenia
Overview How likely is it that the drugs in Neutropenia will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Neutropenia Overview Neutropenia is an abnormally low concentration of neutrophils (a type of...
-
Sector Analysis
NewItaly Power Market Trends and Analysis by Capacity, Generation, Transmission, Distribution, Regulations, Key Players and Forecast to 2035
Italy Power Market Report Overview The Italy power market had a cumulative installed capacity of 128.1 GW in 2023 and will grow at a CAGR of more than 5% during 2023-2035. The industrial sector accounted for the highest share of power consumption across Italy in 2023. Italy Power Market Outlook, 2023-2035 (GW) The market research report discusses the Italian power market structure. It provides historical and forecast numbers for capacity, generation, and consumption up to 2035. The report also analyzes...